Search Results - "Mohell N"

Chemoselective Aza-Michael Addition of Enolizable Heterocyclic Imine-Thiols to Levoglucosenone.

Authors: Mauger, Anastasia Mahato, Rubi Witczak, Zbigniew J. et al.

Source: Molecules. Jan2026, Vol. 31 Issue 1, p164. 9p.

Volume Author index.

Source: FEBS Journal. Dec2006, Vol. 273 Issue 24, p5737-5749. 13p.

Dopamine Partial Agonists in Pregnancy and Lactation: A Systematic Review.

Authors: Koukopoulos, Alexia Janiri, Delfina Milintenda, Miriam et al.

Source: Pharmaceuticals (14248247). Jul2025, Vol. 18 Issue 7, p1010. 29p.

The Role of TP53 Mutations in the Malignant Progression of Mucinous Borderline Ovarian Tumors: A Case Report and Literature Review.

Authors: Liang, Meirong Xie, Sijun Chua, Katherine Jane Chung et al.

Source: International Journal of Women's Health. Sep2025, Vol. 17, p3155-3165. 11p.

Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain.

Authors: Yamamoto, Yasuharu Takahata, Keisuke Kubota, Manabu et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2023, Vol. 50 Issue 13, p3928-3936. 9p.

p53: from understanding its structure to advances in therapeutic targeting.

Authors: Wang W Liu X Liu H et al.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Apr 06; Vol. 11 (1). Date of Electronic Publication: 2026 Apr 06.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Molecular Profile of Intrahepatic Cholangiocarcinoma.

Authors: Andraus, Wellington Tustumi, Francisco de Meira Junior, José Donizeti et al.

Source: International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p461. 18p.

Clozapine N-oxide, compound 21, and JHU37160 do not influence effortful reward-seeking behavior in mice.

Authors: Aomine, Yoshiatsu Oyama, Yoshinobu Sakurai, Koki et al.

Source: Psychopharmacology. Jan2024, Vol. 241 Issue 1, p89-96.

Molecular and Clinical Insights into TP53 -Mutated MDS and AML.

Authors: Georgantzinos, Erotokritos Karantanos, Theodoros

Source: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 22, p10818. 26p.

Molecular Underpinning of Treatment-Resistant Schizophrenia: A Putative Different Neurobiology from Treatment-Responsive Schizophrenia.

Authors: Barone, Annarita Vellucci, Licia Ciccarelli, Mariateresa et al.

Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 17, p8598. 50p.

The role of M1 muscarinic receptor agonism ofN-desmethylclozapine in the unique clinical effects of clozapine.

Authors: Weiner, D. M. Meltzer, H. Y. Veinbergs, I. et al.

Source: Psychopharmacology. 2004, Vol. 177 Issue 1/2, p207-216.

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents.

Authors: Soler‐Cedeño, Omar Keegan, Bradley M. Alton, Hannah et al.

Source: British Journal of Pharmacology. Jul2025, Vol. 182 Issue 13, p2997-3016. 20p.

Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope.

Authors: Brancewicz, Jan Padzińska-Pruszyńska, Irena Barbara Kubiak, Małgorzata et al.

Source: Cells (2073-4409). Jul2025, Vol. 14 Issue 13, p995. 44p.

Polygenetic risk scores and phenotypic constellations of obsessive–compulsive disorder in clozapine-treated schizophrenia.

Authors: Morgenroth, Carla Lou Kleymann, Philipp Ripke, Stephan et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Feb2024, Vol. 274 Issue 1, p181-193. 13p.

Subjects: Disease risk factors, Obsessive-compulsive disorder, Pathological psychology, Phenotypes, Schizophrenia

New N -Adducts of Thiadiazole and Thiazoline with Levoglucosenone and Evaluation of Their Significant Cytotoxic (Anti-Cancer) Activity.

Authors: Poplawski, Tomasz Galita, Grzegorz Sarnik, Joanna et al.

Source: Cancers. Jan2024, Vol. 16 Issue 1, p216. 11p.

Therapeutic potential of NOX inhibitors in neuropsychiatric disorders.

Authors: Kaur, Parneet Khan, Heena Grewal, Amarjot Kaur et al.

Source: Psychopharmacology. Sep2023, Vol. 240 Issue 9, p1825-1840.

Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathway.

Authors: Nie J Jiang H Zhou R et al.

Source: Medical oncology (Northwood, London, England) [Med Oncol] 2026 Apr 20; Vol. 43 (5). Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE

APR-246 drives ROS-dependent ferroptosis and apoptosis and enhances anti-PD-1 efficacy in bladder cancer.

Authors: Zhang C Cao S Zeng G et al.

Source: Scientific reports [Sci Rep] 2026 Mar 15; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 15.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the μ‐opioid receptor.

Authors: Alhosan, Norah Cavallo, Damiana Santiago, Marina et al.

Source: British Journal of Pharmacology. Feb2025, Vol. 182 Issue 4, p969-987. 19p.

Potential Targeted Therapies in Ovarian Cancer.

Authors: Sisman, Yagmur Vestergaard, Lau Kræsing de Oliveira, Douglas Nogueira Perez et al.

Source: Pharmaceuticals (14248247). Nov2022, Vol. 15 Issue 11, p1324. 12p.